NL192821C - Oftalmische oplossing. - Google Patents

Oftalmische oplossing. Download PDF

Info

Publication number
NL192821C
NL192821C NL8500561A NL8500561A NL192821C NL 192821 C NL192821 C NL 192821C NL 8500561 A NL8500561 A NL 8500561A NL 8500561 A NL8500561 A NL 8500561A NL 192821 C NL192821 C NL 192821C
Authority
NL
Netherlands
Prior art keywords
solution
test
ophthalmic solution
ophthalmic
eyes
Prior art date
Application number
NL8500561A
Other languages
English (en)
Dutch (nl)
Other versions
NL192821B (nl
NL8500561A (nl
Original Assignee
Yoshitomi Pharmaceutical
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical, Senju Pharma Co filed Critical Yoshitomi Pharmaceutical
Publication of NL8500561A publication Critical patent/NL8500561A/nl
Publication of NL192821B publication Critical patent/NL192821B/xx
Application granted granted Critical
Publication of NL192821C publication Critical patent/NL192821C/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/22Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NL8500561A 1984-03-01 1985-02-28 Oftalmische oplossing. NL192821C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59039763A JPS60184013A (ja) 1984-03-01 1984-03-01 点眼剤
JP3976384 1984-03-01

Publications (3)

Publication Number Publication Date
NL8500561A NL8500561A (nl) 1985-10-01
NL192821B NL192821B (nl) 1997-11-03
NL192821C true NL192821C (nl) 1998-03-04

Family

ID=12561978

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8500561A NL192821C (nl) 1984-03-01 1985-02-28 Oftalmische oplossing.

Country Status (14)

Country Link
US (1) US4607038A (ko)
JP (1) JPS60184013A (ko)
KR (1) KR920001461B1 (ko)
AU (1) AU580586B2 (ko)
BE (1) BE901792A (ko)
CA (1) CA1256375A (ko)
CH (1) CH662945A5 (ko)
DE (1) DE3507024C2 (ko)
ES (1) ES8607722A1 (ko)
FR (1) FR2560523B1 (ko)
GB (1) GB2154876B (ko)
IT (1) IT1185522B (ko)
NL (1) NL192821C (ko)
PT (1) PT80004B (ko)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2598081B1 (fr) * 1986-04-30 1990-02-02 Chauvin Blache Lab Procede de preparation d'une solution pharmaceutique aqueuse d'un principe actif constitue par un acide organique
US5414011A (en) * 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
US5110493A (en) * 1987-09-11 1992-05-05 Syntex (U.S.A.) Inc. Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
ES2079994B1 (es) * 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
US5382599A (en) * 1993-10-13 1995-01-17 Allergan, Inc. Method of inhibiting protozoan growth in eye care products using a polyvalent cation chelating agent
US5494817A (en) * 1993-12-06 1996-02-27 Allergan, Inc. Sugar-based protease composition for use with constant-PH borate buffers
JP3021312B2 (ja) * 1994-03-15 2000-03-15 千寿製薬株式会社 プラノプロフェンの安定化方法および安定なプラノプロフェン水性液剤
TW358812B (en) * 1994-03-15 1999-05-21 Senju Pharma Co Method for stabilizing pranoprofen and a composition and a package thereof
JP3170619B2 (ja) * 1995-04-20 2001-05-28 参天製薬株式会社 有機アミンを配合したプラノプロフェン点眼液
US5683993A (en) * 1995-06-22 1997-11-04 Ciba Vision Corporation Compositions and methods for stabilizing polymers
US6986740B2 (en) * 1998-11-02 2006-01-17 Xantech Pharmaceuticals, Inc. Ultrasound contrast using halogenated xanthenes
WO2001087304A1 (fr) * 2000-05-17 2001-11-22 Senju Pharmaceutical Co., Ltd. Composition ophtalmique
CN1210028C (zh) * 2000-05-17 2005-07-13 千寿制药株式会社 水性液体制剂
JP3556575B2 (ja) 2000-06-06 2004-08-18 シャープ株式会社 対物レンズ、それを備えた光ピックアップ装置および対物レンズの組立方法
JP2003075703A (ja) * 2001-08-31 2003-03-12 Konica Corp 光学ユニット及び光学装置
JP2003075700A (ja) * 2001-08-31 2003-03-12 Konica Corp 光学ユニット及び光学装置
JP2003075709A (ja) * 2001-08-31 2003-03-12 Konica Corp 光学ユニットの組立方法及び光学ユニットの保持方法並びに光学ユニットの保持部材
JP2003075701A (ja) * 2001-08-31 2003-03-12 Konica Corp 光学ユニット及び光学装置
JP2003075698A (ja) * 2001-08-31 2003-03-12 Konica Corp 光学ユニットの組立方法
JP2003075704A (ja) * 2001-08-31 2003-03-12 Konica Corp 光学ユニット及び光学装置
JP5147156B2 (ja) * 2003-08-08 2013-02-20 ロート製薬株式会社 角膜障害抑制剤
JP2005289899A (ja) * 2004-03-31 2005-10-20 Kobayashi Pharmaceut Co Ltd プラノプロフェンを含有する液状外用剤
JP2010189442A (ja) * 2010-06-07 2010-09-02 Rohto Pharmaceut Co Ltd 角膜障害抑制剤
CN102885768A (zh) * 2012-11-02 2013-01-23 江苏吉贝尔药业有限公司 普拉洛芬原位胶化滴眼剂及其制备方法
WO2014168592A1 (en) * 2013-04-08 2014-10-16 Yeditepe Universitesi Antiviral gel combination
AR102172A1 (es) 2015-10-05 2017-02-08 Química Luar S R L Una composición farmacéutica bactericida y virucida

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1403487A (en) * 1972-07-21 1975-08-28 Yoshitomi Pharmaceutical Heterocyclic substituted alkanoic acids and derivatives
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
DE3026402A1 (de) * 1980-07-11 1982-02-04 Syntex Corp., Palo Alto, Calif. Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen
JPS5829706A (ja) * 1981-08-14 1983-02-22 Toko Yakuhin Kogyo Kk 消炎鎮痛外用剤
JPS58126810A (ja) * 1981-12-24 1983-07-28 Kaken Pharmaceut Co Ltd 抗炎症眼科用液剤およびその製法
JPS597115A (ja) * 1982-07-02 1984-01-14 Yoshitomi Pharmaceut Ind Ltd 消炎鎮痛外用剤
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same

Also Published As

Publication number Publication date
CA1256375A (en) 1989-06-27
CH662945A5 (de) 1987-11-13
FR2560523A1 (fr) 1985-09-06
KR920001461B1 (ko) 1992-02-14
IT8519661A0 (it) 1985-02-27
IT1185522B (it) 1987-11-12
JPS60184013A (ja) 1985-09-19
DE3507024C2 (de) 1994-07-21
KR850006135A (ko) 1985-10-02
PT80004A (en) 1985-03-01
PT80004B (pt) 1987-09-18
BE901792A (fr) 1985-06-17
FR2560523B1 (fr) 1988-11-25
GB2154876B (en) 1987-11-04
US4607038A (en) 1986-08-19
AU3941785A (en) 1985-09-05
DE3507024A1 (de) 1985-09-12
ES540780A0 (es) 1986-06-01
GB2154876A (en) 1985-09-18
NL192821B (nl) 1997-11-03
GB8505050D0 (en) 1985-03-27
NL8500561A (nl) 1985-10-01
AU580586B2 (en) 1989-01-19
ES8607722A1 (es) 1986-06-01
JPH0216728B2 (ko) 1990-04-18

Similar Documents

Publication Publication Date Title
NL192821C (nl) Oftalmische oplossing.
KR100889170B1 (ko) 안구 건조의 치료에 있어서 리멕솔론의 용도
US5110493A (en) Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
JPS62501002A (ja) 高い眼圧の防止法、緑内障の処置及び高眼圧の処置
KR101961360B1 (ko) 신규한 요오드포 조성물 및 사용 방법
JPH1160505A (ja) 防腐組成物
JP2005104862A (ja) 加齢黄斑変性治療剤
DE69208941T2 (de) Augenpräparate mit verlängerter Freigabe
EA012975B1 (ru) Фотостабильная фармацевтическая композиция, содержащая бривудин, для лечения герпетического кератита
WO2019135779A1 (en) Novel ophthalmic composition and methods of use
CA3201220A1 (en) Difluprednate for reducing the adverse effects of ocular inflammation
KR100430428B1 (ko) 설린닥을 함유하는 망막 손상 치료용 안약 조성물과 그제조방법
US20100160342A1 (en) Compositions of Topical Ocular Solutions to Deliver Effective Concentrations of Active Agent to the Posterior Segment of the Eye
EP0375299A1 (en) Combinations of angiotensin converting enzyme, and carbonic anhydrase, inhibitors for treating glaucoma
EP0885612A1 (en) Pirenoxine for the topical treatment of inflammatory conditions
KR950013745B1 (ko) 안과 제제용 방부 시스템
JPH10203979A (ja) チアプロフェン酸を含有する抗眼炎症剤
JPH04327540A (ja) カルシトニン含有医薬
US20180200289A1 (en) Novel ophthalmic composition and methods of use

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
TNT Modifications of names of proprietors of patents or applicants of examined patent applications

Owner name: SENJU PHARMACEUTICAL CO., LTD.;WELFIDE CORPORATION

V1 Lapsed because of non-payment of the annual fee

Effective date: 20040901